We are delighted to announce the successful conclusion of the 5th Edition of the Euro-Global Conference on Biotechnology and Bioengineering (ECBB 2025), held from September 18–20, 2025, in the vibrant city of London, UK.
The conference brought together an outstanding assembly of biotechnologists, bioengineers, researchers, industry professionals, and academic experts from across the globe to share their latest research, technological innovations, and visionary ideas. ECBB 2025 served as an exceptional forum to explore advancements in genetic engineering, bioprocessing, molecular biology, biomedical technologies, and sustainable bio-industries.
Title : Solving the challenges of engineering an ultra-long acting insulin
Tina Moller Tagmose, Novo Nordisk A/S, Denmark
Title : The lines of antigen-antibody interactions in vitro and their significance for sensitive and specific antigen and antibody assays, including hybrid ELISAs, and for the possibility of more efficacious vaccines
Viggo Bitsch, Retired, Independent Researcher, Denmark
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Blood glucose monitoring from voice signal, 5 years later
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Brown University, United States